Structured facts
{
"code": "S",
"date": "2026-05-12",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F3": "Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.",
"F5": "The securities are held by Serendipity BioPharma LLC (\"Serendipity\"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.",
"F7": "Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $50.68 to $56.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
},
"owners": [
{
"cik": "0001231615",
"name": "JEFFS ROGER",
"roles": [
"director",
"officer"
],
"title": "Chief Executive Officer"
}
],
"ownership": "I",
"post_shares": "1273095",
"price": "54.0396",
"row": 3,
"rule_10b5_1": "1",
"security": "Common Stock",
"shares": "25000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}